FREE Daily Stock Alerts From Stock-PR.com
EFI (Nasdaq:EFII), a world leader in customer-focused printing and packaging industry innovation, recently launched a new version of its Radius packaging MIS/ERP solution targeted at the small-to-medium business segment.
The software is an entry-level, fully integrated automation solution ideal for single-site label, flexible packaging, converting and folding carton companies.
Crown Equity Holdings Inc. (OTCPK:CRWE) announces that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.
"In addition to publishing to the mentioned countries, Crown Equity Holdings Inc. has also established online publishing sites for over 660 various cities within those countries," stated Arnulfo Saucedo-Bardan, Chairman of the Board for Crown Equity Holdings Inc.
The company has also established over 1,100 city specific sites within the US, allowing Crown Equity Holdings Inc. to publish its news and information globally or geographically.
"This increases Crown Equity Holdings Inc. online network, which already receives more than 510,000 pages views per month, during its 357,000 visits from over 250,000 people according to a third party media measurement service provider Quantcast," stated Kenneth Bosket, President of Crown Equity Holdings Inc.
The company's wholly owned subsidiary, Crown Tele Services Inc., has completed installing servers for its business, which is currently in the process of preparing to provide and offer its "VoIP" communication services to small, large and enterprise businesses.
Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
For more information, visit http://www.crownequityholdings.com
DARA BioSciences, Inc. ( NASDAQ:DARA) is a clinical biopharmaceutical drug development company, highlights a number of achievements disclosed in the Company's 2010 annual report that was filed with the Securities & Exchange Commission (SEC) on March 25, 2011 and provides an overview. For the year ending December 31, 2010, the Company received approximately $8.4 million in cash and funding commitments to continue the clinical development of its two leading drug candidates that have the potential to help people with neuropathic pain and those with diabetes. As a result of the capital raised during 2010, the Company believes it has sufficient cash to achieve the next series of key milestones during 2011.
DARA BioSciences, Inc., a development-stage pharmaceutical company, acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. DARA BioSciences, Inc. is headquartered in Raleigh, North Carolina.
DARA BioSciences reported today that SurgiVision, Inc., a privately held company, and Brainlab AG, announced on April 11 a collaboration aimed at integrating SurgiVision’s ClearPoint(NYSE:R) product line with Brainlab’s iMRI product line, with particular focus on local delivery of drugs and other therapeutic agents to precision targets in the brain under magnetic resonance imaging (MRI) guidance. DARA presently owns over 500,000 shares and warrants of SurgiVision. Last June, SurgiVision received 510(k) clearance from the Food and Drug Administration (FDA) to market their ClearPoint system in the United States for general neurological interventional procedures.
Brainlab and SurgiVision stated that they believe the integration of their technologies will allow patient-specific treatment planning, simplified clinical workflows and optimal delivery of drugs to the brain. Under the terms of the agreement, Brainlab received the right to sell SurgiVision’s ClearPoint product line, including the right to exclusively sell ClearPoint products in the neurological drug delivery field, and Brainlab made an investment in SurgiVision. SurgiVision will continue to sell its ClearPoint product line directly for all applications outside the neurological drug delivery field.
Presently DARA has two drug candidates with cleared IND (Investigational New Drug) Applications from the United States FDA advancing through clinical development:
1. KRN5500 for the treatment of neuropathic pain — successfully completed a Phase II study and plans to initiate a second Phase II study (Q2 2011) in conjunction with the National Cancer Institute focusing on the treatment of chemotherapy induced peripheral neuropathy (CIPN); and
2. DB959 for the treatment of type 2 diabetes — successfully completed a Phase Ia study and has initiated a Phase Ib study (Q1 2011).
Fox Chase Bancorp, Inc. (Nasdaq:FXCB), holding company for Fox Chase Bank, recently reported that it will host a conference call to discuss its first quarter 2011 results on Friday, April 29, 2011 at 9:00 a.m. EDT. Results are scheduled to be released on Thursday, April 28, 2011.
Limelight Networks, Inc. (Nasdaq:LLNW) recently reported that mgMEDIA chose Limelight's media delivery services to provide an underlying platform for its over-the-top (OTT), global multi-device distribution.
The multi-device platform Open4Content is a four-screen solution that allows the creation of video clubs and other services that can be enjoyed on all devices, including TVs with Internet connection, tablets, smartphones and PCs.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.